Status:

RECRUITING

High-Resolution PET-CT Imaging for Surgical Margin Visualization

Lead Sponsor:

Vanderbilt-Ingram Cancer Center

Collaborating Sponsors:

Vanderbilt University Medical Center

XEOS Medical

Conditions:

Cancer

Solid Malignant Tumors

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Imaging will be exploratory and be used intraoperatively. There have been no discovered risks associated with the device to be used in this study, and none are anticipated given the diagnostic and non...

Detailed Description

This pilot study explores the use of high-resolution PET imaging to identify surgical margins in solid tumors after removal. It evaluates the feasibility and potential of using PET-CT to assess tumor ...

Eligibility Criteria

Inclusion

  • Biopsy confirmed diagnosis of any solid malignancy
  • Diagnosis of any T stage, any subsite that are scheduled to undergo definitive en bloc surgical resection. Patients with recurrent disease or a new primary will be allowed.
  • Planned standard of care oncologic surgery with curative intent
  • Male or female patients age ≥ 18 years
  • Have life expectancy of more than 12 weeks
  • Karnofsky performance status of at least 70% or ECOG/Zubrod level 1
  • Have acceptable glucose status (\<200 mg/dL) at Day of Surgery prior to 18F-FDG injection

Exclusion

  • General or local contraindications for resective surgery
  • Women who are pregnant or breast-feeding
  • Blood glucose level over 200 mg/dL prior to 18F-FDG infusion
  • Any participation in other clinical trials or research study that involved a radiation exposure of more than 1 mSv in the past year. If the participant had radiation exposure greater than 1 mSv as SOC, they would not be excluded unless the Principal Investigator determines that patient could be at risk.

Key Trial Info

Start Date :

September 3 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2027

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT06915454

Start Date

September 3 2025

End Date

July 1 2027

Last Update

October 3 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Vanderbilt University Medical Center

Nashville, Tennessee, United States, 37232